{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T05:39:24Z","timestamp":1794893964035,"version":"4.9.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC-114-2314-B-567-002"],"award-info":[{"award-number":["NSTC-114-2314-B-567-002"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC-113-2314-B-567-001"],"award-info":[{"award-number":["NSTC-113-2314-B-567-001"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009974","name":"Cardinal Tien Hospital","doi-asserted-by":"publisher","award":["CTH-110A-2217"],"award-info":[{"award-number":["CTH-110A-2217"]}],"id":[{"id":"10.13039\/501100009974","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009974","name":"Cardinal Tien Hospital","doi-asserted-by":"publisher","award":["CTH-112A-2215"],"award-info":[{"award-number":["CTH-112A-2215"]}],"id":[{"id":"10.13039\/501100009974","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009974","name":"Cardinal Tien Hospital","doi-asserted-by":"publisher","award":["CTH-113A-NDMC-2233"],"award-info":[{"award-number":["CTH-113A-NDMC-2233"]}],"id":[{"id":"10.13039\/501100009974","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.survophthal.2025.12.009","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T23:28:54Z","timestamp":1767223734000},"page":"878-891","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Comparative effectiveness and safety of intra-arterial chemotherapy and intravenous chemotherapy for retinoblastoma: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"71","author":[{"given":"Kai-Yang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoi-Chun","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Ming","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.survophthal.2025.12.009_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/genes16091031","article-title":"Genetics of retinoblastoma: an overview and significance of genetic testing in clinical practice","volume":"16","author":"Abu-Amero","year":"2025","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.survophthal.2025.12.009_bib2","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.4103\/ijo.IJO_721_20","article-title":"Modern treatment of retinoblastoma: A 2020 review","volume":"68","author":"Ancona-Lezama","year":"2020","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.12.009_bib3","first-page":"431","article-title":"Differential diagnosis of leukocoria and strabismus, first presenting signs of retinoblastoma","volume":"1","author":"Balmer","year":"2007","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.12.009_bib4","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12964-023-01223-z","article-title":"Retinoblastoma: present scenario and future challenges","volume":"21","author":"Byroju","year":"2023","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.survophthal.2025.12.009_bib5","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00280-020-04036-w","article-title":"Evaluating primary intra-arterial chemotherapy versus intravenous plus intra-arterial chemotherapy for advanced intraocular retinoblastoma","volume":"85","author":"Chen","year":"2020","journal-title":"Cancer Chemother Pharm"},{"key":"10.1016\/j.survophthal.2025.12.009_bib6","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/IIO.0000000000000591","article-title":"Intra-arterial chemotherapy for retinoblastoma: real-world experience","volume":"65","author":"Das","year":"2025","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.survophthal.2025.12.009_bib7","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/pbc.20931","article-title":"Retinoblastoma in children older than 5 years of age","volume":"48","author":"de Aguirre Neto","year":"2007","journal-title":"Pedia Blood Cancer"},{"key":"10.1016\/j.survophthal.2025.12.009_bib8","doi-asserted-by":"crossref","DOI":"10.1177\/15910199251324028","article-title":"Comparison of single- versus multi-drug treatment for intra-arterial chemotherapy (IAC) in children with retinoblastoma","author":"Fulton","year":"2025","journal-title":"Inter Neuroradiol"},{"key":"10.1016\/j.survophthal.2025.12.009_bib9","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/archophthalmol.2011.5","article-title":"Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience","volume":"129","author":"Gobin","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.12.009_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12082304","article-title":"Retinoblastoma: Etiology, modeling, and treatment","volume":"12","author":"Kaewkhaw","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.survophthal.2025.12.009_bib11","article-title":"Update on chemotherapy modalities for retinoblastoma: progress and challenges","volume":"13","author":"Kritfuangfoo","year":"2024","journal-title":"Asia Pac J Ophthalmol (Philos"},{"key":"10.1016\/j.survophthal.2025.12.009_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10225421","article-title":"Changes in treatment patterns and globe salvage rate of advanced retinoblastoma in Korea: efficacy of intra-arterial chemotherapy","volume":"10","author":"Lee","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.survophthal.2025.12.009_bib13","article-title":"Intra-arterial chemotherapy as primary treatment for advanced unilateral retinoblastoma in China","volume":"9","author":"Liang","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.survophthal.2025.12.009_bib14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s40246-023-00529-w","article-title":"Genetics in ophthalmology: molecular blueprints of retinoblastoma","volume":"17","author":"Markovi\u0107","year":"2023","journal-title":"Hum Genom"},{"key":"10.1016\/j.survophthal.2025.12.009_bib15","article-title":"Update on Retinoblastoma Therapies","volume":"61","author":"Mart\u00ednez Arce","year":"2025","journal-title":"Med (Kaunas)"},{"key":"10.1016\/j.survophthal.2025.12.009_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101056","article-title":"Chemotherapeutic drugs: Cell death- and resistance-related signaling pathways. Are they really as smart as the tumor cells?","volume":"14","author":"Mollaei","year":"2021","journal-title":"Transl Oncol"},{"key":"10.1016\/j.survophthal.2025.12.009_bib17","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/IAE.0b013e318203c101","article-title":"Occurrence of sectoral choroidal occlusive vasculopathy and retinal arteriolar embolization after superselective ophthalmic artery chemotherapy for advanced intraocular retinoblastoma","volume":"31","author":"Munier","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2025.12.009_bib18","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1136\/bjophthalmol-2016-309298","volume":"101","author":"Munier","year":"2017","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"10.1016\/j.survophthal.2025.12.009_bib19","article-title":"Comparison of the clinical outcomes of ophthalmic artery chemotherapy with systemic vein-eye artery chemotherapy for retinoblastoma in children","volume":"40","author":"Qi","year":"2022","journal-title":"Chin J Exp Ophthalmo"},{"key":"10.1016\/j.survophthal.2025.12.009_bib20","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/archophthalmol.2011.2825","article-title":"Intravenous chemoreduction or intra-arterial chemotherapy for cavitary retinoblastoma: long-term results","volume":"130","author":"Rojanaporn","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.12.009_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaapos.2019.08.031","article-title":"Comparison of outcomes, adverse events, and treatment burden of intravenous chemotherapy versus intra-arterial chemotherapy for retinoblastoma: results of a pilot study","volume":"23","author":"Santapuram","year":"2019","journal-title":"J Am Assoc Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.survophthal.2025.12.009_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.822330","article-title":"Treatment of Retinoblastoma: What Is the Latest and What Is the Future","volume":"12","author":"Schaiquevich","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.survophthal.2025.12.009_bib23","first-page":"169","article-title":"Pharmacotherapy for retinoblastoma","volume":"4","author":"Shahsavari","year":"2009","journal-title":"J Ophthalmic Vis Res"},{"key":"10.1016\/j.survophthal.2025.12.009_bib24","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/archophthalmol.2011.150","article-title":"Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds","volume":"129","author":"Shields","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.12.009_bib25","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0002-9394(02)01348-X","article-title":"Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation","volume":"133","author":"Shields","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.12.009_bib26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/APO.0000000000000172","article-title":"Unilateral Retinoblastoma Managed With Intravenous Chemotherapy Versus Intra-Arterial Chemotherapy. Outcomes Based on the International Classification of Retinoblastoma","volume":"5","author":"Shields","year":"2016","journal-title":"Asia Pac J Ophthalmol (Philos"},{"key":"10.1016\/j.survophthal.2025.12.009_bib27","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.oret.2025.02.013","article-title":"Intra-arterial Chemotherapy for Retinoblastoma, Outcomes Analysis in 357 Eyes: Thirteen Years of Experience in a Referral Center in Brazil","volume":"9","author":"Teixeira","year":"2025","journal-title":"Ophthalmol Retin"},{"key":"10.1016\/j.survophthal.2025.12.009_bib28","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1136\/bjo-2025-327728","article-title":"Intra-arterial chemotherapy for retinoblastoma: a performance analysis","volume":"109","author":"Weinberger","year":"2025","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.12.009_bib29","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S2352-4642(23)00141-4","article-title":"Intravenous versus super-selected intra-arterial chemotherapy in children with advanced unilateral retinoblastoma: an open-label, multicentre, randomised trial","volume":"7","author":"Wen","year":"2023","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.survophthal.2025.12.009_bib30","first-page":"1199","article-title":"Intra-arterial chemotherapy combined with VEC intravenous chemotherapy in the treatment of advanced retinoblastoma","volume":"25","author":"Xu","year":"2020","journal-title":"J buon"},{"key":"10.1016\/j.survophthal.2025.12.009_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17121955","article-title":"Intra-arterial melphalan chemotherapy for retinoblastoma in a developing nation: real-world outcomes and prognostic factors","volume":"17","author":"Yousef","year":"2025","journal-title":"Cancers (Basel)"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625725002346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625725002346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T11:55:48Z","timestamp":1781006148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625725002346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0039625725002346"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2025.12.009","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative effectiveness and safety of intra-arterial chemotherapy and intravenous chemotherapy for retinoblastoma: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2025.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}